{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:22:21Z","timestamp":1787829741408,"version":"build-2784847793"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Science Research Project of Hebei","award":["20240186"],"award-info":[{"award-number":["20240186"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-56986-5","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T08:55:50Z","timestamp":1781254550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An exploratory multimodal pipeline for recurrence prediction in CRC with XELOX therapy"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhihan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"issue":"1","key":"56986_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/jcm13010040","volume":"13","author":"R Marcellinaro","year":"2023","unstructured":"Marcellinaro, R. et al. Colorectal Cancer: Current Updates and Future Perspectives. J. Clin. Med. 13 (1), 40 (2023).","journal-title":"J. Clin. Med."},{"issue":"2","key":"56986_CR2","first-page":"e223","volume":"18","author":"SY Guraya","year":"2019","unstructured":"Guraya, S. Y. Pattern, Stage, and Time of Recurrent Colorectal Cancer After Curative Surgery. Clin. Colorectal Cancer. 18 (2), e223\u2013e228 (2019).","journal-title":"Clin. Colorectal Cancer"},{"issue":"24","key":"56986_CR3","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1200\/JCO.21.02615","volume":"40","author":"M Malla","year":"2022","unstructured":"Malla, M., Loree, J. M., Kasi, P. M. & Parikh, A. R. Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices. J. Clin. Oncol. 40 (24), 2846\u20132857 (2022).","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"56986_CR4","doi-asserted-by":"publisher","first-page":"10230","DOI":"10.3390\/ijms241210230","volume":"24","author":"A Chidharla","year":"2023","unstructured":"Chidharla, A. et al. Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis. Int. J. Mol. Sci. 24 (12), 10230 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"56986_CR5","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41591-025-03579-w","volume":"31","author":"J Tie","year":"2025","unstructured":"Tie, J. et al. Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial. Nat. Med. 31 (3), 654\u2013663 (2025).","journal-title":"Nat. Med."},{"issue":"1","key":"56986_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/ijc.30053","volume":"139","author":"SR Verhoeff","year":"2016","unstructured":"Verhoeff, S. R., van Erning, F. N., Lemmens, V. E., de Wilt, J. H. & Pruijt, J. F. Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer. Int. J. Cancer. 139 (1), 187\u2013193 (2016).","journal-title":"Int. J. Cancer"},{"issue":"4","key":"56986_CR7","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s43018-025-00960-z","volume":"6","author":"J Mart\u00edn-Arana","year":"2025","unstructured":"Mart\u00edn-Arana, J. et al. Whole-exome tumor-agnostic ctDNA analysis enhances minimal residual disease detection and reveals relapse mechanisms in localized colon cancer. Nat. Cancer. 6 (4), 480\u2013492 (2025).","journal-title":"Nat. Cancer"},{"issue":"8","key":"56986_CR8","doi-asserted-by":"publisher","first-page":"e1003741","DOI":"10.1371\/journal.pmed.1003741","volume":"18","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study. PLoS Med. 18 (8), e1003741 (2021).","journal-title":"PLoS Med."},{"issue":"1","key":"56986_CR9","doi-asserted-by":"publisher","first-page":"e6884","DOI":"10.1002\/cam4.6884","volume":"13","author":"E Vail","year":"2024","unstructured":"Vail, E. et al. Recurrence-free survival dynamics following adjuvant chemotherapy for resected colorectal cancer: A systematic review of randomized controlled trials. Cancer Med. 13 (1), e6884 (2024).","journal-title":"Cancer Med."},{"issue":"6","key":"56986_CR10","doi-asserted-by":"publisher","first-page":"837","DOI":"10.5858\/134.6.837","volume":"134","author":"G Puppa","year":"2010","unstructured":"Puppa, G., Sonzogni, A., Colombari, R. & Pelosi, G. TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues. Arch. Pathol. Lab. Med. 134 (6), 837\u2013852 (2010).","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"3","key":"56986_CR11","doi-asserted-by":"publisher","first-page":"O82","DOI":"10.1111\/codi.12506","volume":"16","author":"JE Mart\u00edn-L\u00f3pez","year":"2014","unstructured":"Mart\u00edn-L\u00f3pez, J. E., Beltr\u00e1n-Calvo, C., Rodr\u00edguez-L\u00f3pez, R. & Molina-L\u00f3pez, T. Comparison of the accuracy of CT colonography and colonoscopy in the diagnosis of colorectal cancer. Colorectal Dis. 16 (3), O82\u2013O89 (2014).","journal-title":"Colorectal Dis."},{"issue":"1","key":"56986_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13045-022-01358-5","volume":"15","author":"X Zhong","year":"2022","unstructured":"Zhong, X. et al. Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications. J. Hematol. Oncol. 15 (1), 160 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"56986_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2147\/CMAR.S407930","volume":"15","author":"J Hong","year":"2023","unstructured":"Hong, J. et al. Clinical Value of Combined Detection of Serum sTim-3 and CEA or CA19-9 for Postoperative Recurrence of Colorectal Cancer Diagnosis. Cancer Manag Res. 15, 563\u2013572 (2023).","journal-title":"Cancer Manag Res."},{"issue":"11","key":"56986_CR14","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1158\/0008-5472.CAN-18-3402","volume":"79","author":"G Rossi","year":"2019","unstructured":"Rossi, G. & Ignatiadis, M. Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine. Cancer Res. 79 (11), 2798\u20132804 (2019).","journal-title":"Cancer Res."},{"issue":"9","key":"56986_CR15","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","volume":"14","author":"G Siravegna","year":"2017","unstructured":"Siravegna, G., Marsoni, S., Siena, S. & Bardelli, A. Integrating liquid biopsies into the management of cancer. Nat. Rev. Clin. Oncol. 14 (9), 531\u2013548 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"56986_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40364-022-00403-2","volume":"10","author":"S Ju","year":"2022","unstructured":"Ju, S. et al. Detection of circulating tumor cells: opportunities and challenges. Biomark. Res. 10 (1), 58 (2022).","journal-title":"Biomark. Res."},{"issue":"13","key":"56986_CR17","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.3390\/cancers14133249","volume":"14","author":"G Mazzaschi","year":"2022","unstructured":"Mazzaschi, G. et al. Integrated MRI-Immune-Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma. Cancers (Basel). 14 (13), 3249 (2022).","journal-title":"Cancers (Basel)"},{"issue":"146","key":"56986_CR18","first-page":"7","volume":"27","author":"A Allarakha","year":"2019","unstructured":"Allarakha, A., Gao, Y., Jiang, H. & Wang, P. J. Prediction and prognosis of biologically aggressive breast cancers by the combination of DWI\/DCE-MRI and immunohistochemical tumor markers. Discov Med. 27 (146), 7\u201315 (2019).","journal-title":"Discov Med."},{"issue":"10","key":"56986_CR19","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1093\/annonc\/mdx324","volume":"28","author":"YQ Li","year":"2017","unstructured":"Li, Y. Q., Song, S. S., Jiang, S. H. & Zhang, X. Y. Combination therapy of erlotinib\/crizotinib in a lung adenocarcinoma patient with primary EGFR mutation plus secondary MET amplification and a novel acquired crizotinib-resistant mutation MET G1108C. Ann. Oncol. 28 (10), 2622\u20132624 (2017).","journal-title":"Ann. Oncol."},{"issue":"2","key":"56986_CR20","doi-asserted-by":"publisher","first-page":"fcad074","DOI":"10.1093\/braincomms\/fcad074","volume":"5","author":"MF Iulita","year":"2023","unstructured":"Iulita, M. F. et al. Association of biological sex with clinical outcomes and biomarkers of Alzheimer\u2019s disease in adults with Down syndrome. Brain Commun. 5 (2), fcad074 (2023).","journal-title":"Brain Commun."},{"issue":"9","key":"56986_CR21","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/s41587-021-00857-z","volume":"39","author":"IW Deveson","year":"2021","unstructured":"Deveson, I. W. et al. Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology. Nat. Biotechnol. 39 (9), 1115\u20131128 (2021).","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"56986_CR22","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/ags3.12576","volume":"6","author":"H Yamamoto","year":"2022","unstructured":"Yamamoto, H. Micrometastasis in lymph nodes of colorectal cancer. Ann. Gastroenterol. Surg. 6 (4), 466\u2013473 (2022).","journal-title":"Ann. Gastroenterol. Surg."},{"key":"56986_CR23","first-page":"1","volume":"344","author":"WH Fridman","year":"2011","unstructured":"Fridman, W. H. et al. Immune infiltration in human cancer: prognostic significance and disease control. Curr. Top. Microbiol. Immunol. 344, 1\u201324 (2011).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"56986_CR24","doi-asserted-by":"publisher","first-page":"2397863","DOI":"10.1155\/2018\/2397863","volume":"2018","author":"G Pellino","year":"2018","unstructured":"Pellino, G. et al. Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalized Treatment Perspectives. Gastroenterol. Res. Pract. 2018, 2397863 (2018).","journal-title":"Gastroenterol. Res. Pract."},{"issue":"7","key":"56986_CR25","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/bjc.2016.274","volume":"115","author":"AC Rogers","year":"2016","unstructured":"Rogers, A. C. et al. Systematic review and meta-analysis of the impact of tumor budding in colorectal cancer. Br. J. Cancer. 115 (7), 831\u2013840 (2016).","journal-title":"Br. J. Cancer"},{"issue":"8","key":"56986_CR26","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1177\/0962280218784726","volume":"28","author":"M van Smeden","year":"2019","unstructured":"van Smeden, M. et al. Sample size for binary logistic prediction models: Beyond events per variable criteria. Stat. Methods Med. Res. 28 (8), 2455\u20132474 (2019).","journal-title":"Stat. Methods Med. Res."},{"issue":"1","key":"56986_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41591-019-0724-8","volume":"26","author":"NS Artzi","year":"2020","unstructured":"Artzi, N. S. et al. Prediction of gestational diabetes based on nationwide electronic health records. Nat. Med. 26 (1), 71\u201376 (2020).","journal-title":"Nat. Med."},{"key":"56986_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.artmed.2016.07.003","volume":"72","author":"M Jovanovic","year":"2016","unstructured":"Jovanovic, M., Radovanovic, S., Vukicevic, M., Van Poucke, S. & Delibasic, B. Building interpretable predictive models for pediatric hospital readmission using Tree-Lasso logistic regression. Artif. Intell. Med. 72, 12\u201321 (2016).","journal-title":"Artif. Intell. Med."},{"key":"56986_CR29","first-page":"671976","volume":"11","author":"X Zhao","year":"2021","unstructured":"Zhao, X. et al. The Potential Use of Dynamics Changes of ctDNA and cfDNA in the Perioperative Period to Predict the Recurrence Risk in Early NSCLC. Front. Oncol. 11, 671976 (2021).","journal-title":"Front. Oncol."},{"issue":"3","key":"56986_CR30","first-page":"256","volume":"20","author":"B Mitrovic","year":"2021","unstructured":"Mitrovic, B. et al. Prognostic and Predictive Value of Tumor Budding in Colorectal Cancer. Clin. Colorectal Cancer. 20 (3), 256\u2013264 (2021).","journal-title":"Clin. Colorectal Cancer"},{"issue":"6","key":"56986_CR31","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3393\/ac.2019.11.13","volume":"35","author":"C Hall","year":"2019","unstructured":"Hall, C. et al. A Review of the Role of Carcinoembryonic Antigen in Clinical Practice. Ann. Coloproctol. 35 (6), 294\u2013305 (2019).","journal-title":"Ann. Coloproctol"},{"issue":"6","key":"56986_CR32","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3390\/cancers12061376","volume":"12","author":"D Kolen\u010d\u00edk","year":"2020","unstructured":"Kolen\u010d\u00edk, D. et al. Liquid Biopsy in Colorectal Carcinoma: Clinical Applications and Challenges. Cancers (Basel). 12 (6), 1376 (2020).","journal-title":"Cancers (Basel)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56986-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56986-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56986-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:03:10Z","timestamp":1787828590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56986-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["56986"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-56986-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"28 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The present study was approved by the Ethics Committee of the Fourth Hospital of Hebei Medical University. The research was performed in accordance with the World Medical Association Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"26828"}}